NCT04380142foslevodopaParkinson’s diseaseLDp/CDporal antibioticsLDp
…nts receiving LDp/CDp in a 12-week, phase 3, randomized study ( NCT04380142). ISEs were recorded by investigators, including median time to…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT04380142 ×
NCT04380142
This institution is selected. Its supporting articles are shown below.